Fingerprint
Dive into the research topics of 'A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Carl M. Gay, Yanhong Zhou, J. Jack Lee, Xi Ming Tang, Wei Lu, Ignacio I. Wistuba, Renata Ferrarotto, Don L. Gibbons, Bonnie S. Glisson, Merrill S. Kies, George R. Simon, John V. Heymach, Anne S. Tsao
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations